Net profit of ERIS Lifesciences declined 25.80% to Rs 91.59 crore in the quarter ended September 2024 as against Rs 123.43 crore during the previous quarter ended September 2023. Sales rose 47.64% to Rs 738.95 crore in the quarter ended September 2024 as against Rs 500.52 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 738.95 | 500.52 | 48 |
| OPM % | 35.80 | 36.19 | - |
| PBDT | 209.59 | 168.33 | 25 |
| PBT | 129.11 | 126.24 | 2 |
| NP | 91.59 | 123.43 | -26 |